Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers

NCT05995119 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Fasting
Fed

Interventions

DRUG: Apixaban 5 mg Oral Dissolving Film (TAH3311) and Tablet (Eliquis®)

Sponsor

TAHO Pharmaceuticals Ltd.